Koukan Clinic
Kawasaki, Japan
General hospital in Kawasaki
1 Chome-2-1 Kokandori, Kawasaki Ward, Kawasaki, Kanagawa 210-0852
About Koukan Clinic
"内科／呼吸器内科／循環器内科／消化器内科／肝臓内科／糖尿病内分泌内科／腎臓内科／神経内科／血液内科 外科／消化器外科／乳腺外科／血管外科／肛門外科／脳神経外科 整形外科／耳鼻咽喉科／皮膚科／泌尿器科／眼科／小児科／精神科／婦人科 救急科／リハビリテーション科／放射線科／病理診断科／歯科口腔外科／麻酔科"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Bayer
2
Boehringer Ingelheim
1
Janssen Research & Development, LLC
1
Clinical Trials at Koukan Clinic
During the past decade, Koukan Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
2017-03-15
2018-10-02
Terminated
421
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
2017-12-12
2019-10-11
Completed
162
A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
2017-12-13
2019-11-28
Completed
164
A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus
2018-02-06
2019-12-26
Completed
72
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
2019-01-31
2025-01-31
Active, not recruiting
6,609
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Koukan Clinic"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Koukan Clinic
According to Clinical.Site data, the most researched conditions in "Koukan Clinic" are
"Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Koukan Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Koukan Clinic
Most popular intervention types in "Koukan Clinic" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Darbepoetin alfa" (2 trials), "Lanabecestat" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "Placebo" (2 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Koukan Clinic
The vast majority of trials in "Koukan Clinic" are
6 trials for "All" genders.
Clinical Trials Status at Koukan Clinic
Currently, there are NaN active trials in "Koukan Clinic".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Koukan Clinic,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Koukan Clinic, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".